
Tianjin Medical Journal ›› 2026, Vol. 54 ›› Issue (7): 699-704.doi: 10.11958/20253579
• Experimental Research • Previous Articles Next Articles
LYU Dapeng1(
), ZHOU Hongrong1, LI Dan1, ZHOU Na2
Received:2025-12-11
Revised:2026-03-17
Published:2026-07-15
Online:2026-07-13
LYU Dapeng, ZHOU Hongrong, LI Dan, ZHOU Na. The effect of remifentanil on cartilage damage in osteoarthritis rats by regulating the HIF-1α/BNIP3 pathway[J]. Tianjin Medical Journal, 2026, 54(7): 699-704.
CLC Number:
| 组别 | IL-18 | IL-10 | |||
|---|---|---|---|---|---|
| Sham组 | 9.43±1.28 | 38.54±4.73 | |||
| OA组 | 47.68±5.93a | 6.29±0.84a | |||
| Rem-L组 | 34.52±4.61b | 17.36±2.58b | |||
| Rem-H组 | 23.76±3.14bc | 29.62±3.71bc | |||
| Rem-H+YC-1组 | 38.29±4.72d | 14.81±1.96d | |||
| F | 119.339** | 72.948** | |||
| 组别 | MCP-1 | CTX-Ⅰ | CTX-Ⅱ | ||
| Sham组 | 11.74±1.59 | 11.24±1.68 | 8.06±1.17 | ||
| OA组 | 56.48±7.16a | 29.67±3.82a | 19.58±2.34a | ||
| Rem-L组 | 39.51±5.74b | 22.43±3.27b | 15.62±1.93b | ||
| Rem-H组 | 21.65±3.28bc | 15.36±1.94bc | 11.37±1.48bc | ||
| Rem-H+YC-1组 | 42.92±5.87d | 24.75±3.53d | 16.83±1.56d | ||
| F | 119.570** | 61.429** | 68.734** | ||
Tab.1 Comparison of serum levels of IL-18, IL-10, MCP-1, CTX-Ⅰ and CTX-Ⅱ between the five groups of rats (n=10,ng/L,$\stackrel{-}{x}\pm s$)
| 组别 | IL-18 | IL-10 | |||
|---|---|---|---|---|---|
| Sham组 | 9.43±1.28 | 38.54±4.73 | |||
| OA组 | 47.68±5.93a | 6.29±0.84a | |||
| Rem-L组 | 34.52±4.61b | 17.36±2.58b | |||
| Rem-H组 | 23.76±3.14bc | 29.62±3.71bc | |||
| Rem-H+YC-1组 | 38.29±4.72d | 14.81±1.96d | |||
| F | 119.339** | 72.948** | |||
| 组别 | MCP-1 | CTX-Ⅰ | CTX-Ⅱ | ||
| Sham组 | 11.74±1.59 | 11.24±1.68 | 8.06±1.17 | ||
| OA组 | 56.48±7.16a | 29.67±3.82a | 19.58±2.34a | ||
| Rem-L组 | 39.51±5.74b | 22.43±3.27b | 15.62±1.93b | ||
| Rem-H组 | 21.65±3.28bc | 15.36±1.94bc | 11.37±1.48bc | ||
| Rem-H+YC-1组 | 42.92±5.87d | 24.75±3.53d | 16.83±1.56d | ||
| F | 119.570** | 61.429** | 68.734** | ||
| 组别 | Mankin评分/分 | 凋亡率/% |
|---|---|---|
| Sham组 | 0.40±0.07 | 1.34±0.17 |
| OA组 | 9.60±1.38a | 19.86±2.41a |
| Rem-L组 | 7.30±1.16b | 14.75±1.83b |
| Rem-H组 | 4.50±0.74bc | 7.63±0.94bc |
| Rem-H+YC-1组 | 7.90±1.23d | 15.92±1.78d |
| F | 121.938** | 205.273** |
Tab.2 Comparison of Mankin score of articular cartilage and apoptosis rate of chondrocytes between the five groups of rats (n=10,$\stackrel{-}{x}\pm s$)
| 组别 | Mankin评分/分 | 凋亡率/% |
|---|---|---|
| Sham组 | 0.40±0.07 | 1.34±0.17 |
| OA组 | 9.60±1.38a | 19.86±2.41a |
| Rem-L组 | 7.30±1.16b | 14.75±1.83b |
| Rem-H组 | 4.50±0.74bc | 7.63±0.94bc |
| Rem-H+YC-1组 | 7.90±1.23d | 15.92±1.78d |
| F | 121.938** | 205.273** |
| 组别 | NO/(ng/L) | MDA/(mol/g) | SOD/(U/mg) |
|---|---|---|---|
| Sham组 | 18.47±2.16 | 2.09±0.28 | 83.52±10.64 |
| OA组 | 93.12±12.84a | 8.34±1.16a | 17.68±2.23a |
| Rem-L组 | 65.83±7.92b | 6.25±0.79b | 39.47±5.48b |
| Rem-H组 | 42.76±5.41bc | 3.81±0.45bc | 62.93±8.17bc |
| Rem-H+YC-1组 | 71.54±9.38d | 6.67±0.84d | 34.26±4.72d |
| F | 117.033** | 103.419** | 140.391** |
Tab.3 Comparison of NO,MDA contents and SOD activity in cartilage tissue between the five groups of rats (n=10,$\stackrel{-}{x}\pm s$)
| 组别 | NO/(ng/L) | MDA/(mol/g) | SOD/(U/mg) |
|---|---|---|---|
| Sham组 | 18.47±2.16 | 2.09±0.28 | 83.52±10.64 |
| OA组 | 93.12±12.84a | 8.34±1.16a | 17.68±2.23a |
| Rem-L组 | 65.83±7.92b | 6.25±0.79b | 39.47±5.48b |
| Rem-H组 | 42.76±5.41bc | 3.81±0.45bc | 62.93±8.17bc |
| Rem-H+YC-1组 | 71.54±9.38d | 6.67±0.84d | 34.26±4.72d |
| F | 117.033** | 103.419** | 140.391** |
| 组别 | MMP-3/β-actin | MMP-13/β-actin | LC3Ⅱ/LC3Ⅰ | |||
|---|---|---|---|---|---|---|
| Sham组 | 0.31±0.05 | 0.39±0.06 | 0.95±0.12 | |||
| OA组 | 1.07±0.13a | 1.25±0.16a | 0.28±0.04a | |||
| Rem-L组 | 0.82±0.10b | 0.93±0.12b | 0.46±0.07b | |||
| Rem-H组 | 0.57±0.08bc | 0.65±0.08bc | 0.78±0.10bc | |||
| Rem-H+YC-1组 | 0.89±0.11d | 0.98±0.12d | 0.41±0.06d | |||
| F | 91.670** | 84.317** | 112.362** | |||
| 组别 | p62/β-actin | HIF-1α/β-actin | BNIP3/β-actin | |||
| Sham组 | 0.16±0.03 | 0.85±0.11 | 1.41±0.17 | |||
| OA组 | 0.72±0.09a | 0.24±0.04a | 0.43±0.06a | |||
| Rem-L组 | 0.54±0.07b | 0.48±0.07b | 0.76±0.09b | |||
| Rem-H组 | 0.35±0.05bc | 0.67±0.09bc | 1.12±0.14bc | |||
| Rem-H+YC-1组 | 0.59±0.08d | 0.43±0.06d | 0.63±0.08d | |||
| F | 105.417** | 90.149** | 115.878** | |||
Tab.4 Comparison of protein expression levels of MMP-3, MMP-13, LC3Ⅱ/LC3Ⅰ, p62, HIF-1α and BNIP3 in cartilage tissue between the five groups of rats (n=10,$\stackrel{-}{x}\pm s$)
| 组别 | MMP-3/β-actin | MMP-13/β-actin | LC3Ⅱ/LC3Ⅰ | |||
|---|---|---|---|---|---|---|
| Sham组 | 0.31±0.05 | 0.39±0.06 | 0.95±0.12 | |||
| OA组 | 1.07±0.13a | 1.25±0.16a | 0.28±0.04a | |||
| Rem-L组 | 0.82±0.10b | 0.93±0.12b | 0.46±0.07b | |||
| Rem-H组 | 0.57±0.08bc | 0.65±0.08bc | 0.78±0.10bc | |||
| Rem-H+YC-1组 | 0.89±0.11d | 0.98±0.12d | 0.41±0.06d | |||
| F | 91.670** | 84.317** | 112.362** | |||
| 组别 | p62/β-actin | HIF-1α/β-actin | BNIP3/β-actin | |||
| Sham组 | 0.16±0.03 | 0.85±0.11 | 1.41±0.17 | |||
| OA组 | 0.72±0.09a | 0.24±0.04a | 0.43±0.06a | |||
| Rem-L组 | 0.54±0.07b | 0.48±0.07b | 0.76±0.09b | |||
| Rem-H组 | 0.35±0.05bc | 0.67±0.09bc | 1.12±0.14bc | |||
| Rem-H+YC-1组 | 0.59±0.08d | 0.43±0.06d | 0.63±0.08d | |||
| F | 105.417** | 90.149** | 115.878** | |||
| [1] | Yang H, Zhou Y, Ying B, et al. Effects of human umbilical cord mesenchymal stem cell-derived exosomes in the rat osteoarthritis models[J]. Stem Cells Transl Med, 2024, 13(8):803-811. doi:10.1093/stcltm/szae031. |
| [2] | Chen H, Liu S, Xing J, et al. Orientin alleviates chondrocyte senescence and osteoarthritis by inhibiting PI3K/AKT pathway[J]. Bone Joint Res, 2025, 14(3):245-258. doi:10.1302/2046-3758.143.BJR-2023-0383.R2. |
| [3] | Yao Q, Wu X H, Tao C, et al. Osteoarthritis:pathogenic signaling pathways and therapeutic targets[J]. Signal Transduct Target Ther, 2023, 8(1):56. doi:10.1038/s41392-023-01330-w. |
| [4] | Feng W, Feng X, Wu S. The regulatory effect of remifentanil on JNK signaling during remission of flap ischemia-reperfusion injury[J]. Discov Med, 2024, 36(189):2098-2110. doi:10.24976/Discov.Med.202436189.194. |
| [5] | Ke H, Mou X, Xia Q. Remifentanil repairs cartilage damage and reduces the degradation of cartilage matrix in post-traumatic osteoarthritis,and inhibits IL-1β-induced apoptosis of articular chondrocytes via inhibition of PI3K/AKT/NF-κB phosphorylation[J]. Ann Transl Med, 2020, 8(22):1487. doi:10.21037/atm-20-6000. |
| [6] | Lu J, Peng Y, Zou J, et al. Hypoxia inducible factor-1α is a regulator of autophagy in osteoarthritic chondrocytes[J]. Cartilage, 2021, 13(2_suppl):1030S-1040S. doi:10.1177/19476035211035434. |
| [7] | Ke D, Ma Y, Chen J, et al. Molecular mechanism of hydroxyl safflower yellow A in knee osteoarthritis through modulation of autophagy via inhibition of the HIF-1α/BNIP3 pathway[J]. J Vis Exp, 2025, 9(225):e69491. doi:10.3791/69491. |
| [8] | 方大海, 刘健, 刘胜锋, 等. 新风胶囊调节PI3K/AKT信号通路减轻骨关节炎大鼠炎症及骨代谢紊乱的机制研究[J]. 时珍国医国药, 2026, 37(3):417-423. |
| Fang D H, Liu J, Liu S F, et al. Mechanism of Xinfeng Capsule in regulating the PI3K/AKT signaling pathway to alleviate inflammation and bone metabolism disorder in osteoarthritis rats[J]. Journal of Li-Shizhen Traditional Chinese Medicine, 2026, 37(3):417-423. doi:10.70976/j.1008-0805.SZGYGY-2026-0303. | |
| [9] | 贾君杰, 邢海帆, 张群子, 等. 缺氧诱导因子-1α抑制剂YC-1改善糖尿病肾病小鼠肾脏损伤的机制研究[J]. 上海交通大学学报(医学版), 2023, 43(9):1089-1098. |
| Jia J J, Xing H F, Zhang Q Z, et al. Renal protective effect and mechanism research of hypoxia inducible factor-1α inhibitor YC-1 in diabetic nephropathy mice[J]. Journal of Shanghai Jiaotong University(Medical Science), 2023, 43(9):1089-1098. doi:10.3969/j.issn.1674-8115.2023.09.003. | |
| [10] | 王柯, 叶寒露. 隐丹参酮调节HIF-1α/BNIP3信号通路对兔膝骨关节炎模型软骨细胞自噬和凋亡的影响[J]. 天津医药, 2024, 52(4):372-378. |
| Wang K, Ye H L. Impacts of cryptotanshinone on autophagy and apoptosis of chondrocytes in rabbit model of knee osteoarthritis by regulating HIF-1α/BNIP3 signaling pathway[J]. Tianjin Med J, 2024, 52(4):372-378. doi:10.11958/20230861. | |
| [11] | Tang Z, Shu L, Cao Z, et al. Osteoarthritis rat serum-derived extracellular vesicles aggravate osteoarthritis development by inducing NLRP3-mediated pyroptotic cell death and cellular inflammation[J]. Hum Cell, 2024, 37(6):1624-1637. doi:10.1007/s13577-024-01119-1. |
| [12] | Ruan H, Zhu T, Wang T, et al. Quercetin modulates ferroptosis via the SIRT1/Nrf-2/HO-1 pathway and attenuates cartilage destruction in an osteoarthritis rat model[J]. Int J Mol Sci, 2024, 25(13):7461. doi:10.3390/ijms25137461. |
| [13] | Hao G, Wu J, Yu S, et al. Remifentanil vs. dexmedetomidine for cardiac surgery patients with noninvasive ventilation intolerance:a multicenter randomized controlled trial[J]. J Intensive Care, 2024, 12(1):35. doi:10.1186/s40560-024-00750-2. |
| [14] | 管小明, 肖扬, 苏博源. 右美托咪定由NF-κB/CX3CL1途径改善碘乙酸钠诱导的骨关节炎大鼠软骨损伤和疼痛的机制[J]. 河北医药, 2024, 46(7):965-970. |
| Guan X M, Xiao Y, Su B Y. Underlying mechanism on intra-articular injection of dexmedetomidine in alleviating cartilage damage and pain in monosodium iodoacetate-induced osteoarthritis rats by regulating the NF-κB/CX3CL1signaling pathway[J]. Hebei Med J, 2024, 46(7):965-970. doi:10.3969/j.issn.1002-7386.2024.07.001. | |
| [15] | 李秀芳, 郝泉水, 高雄, 等. SIRT1-NLRP3轴介导的细胞焦亡在瑞芬太尼抗肝脏缺血-再灌注损伤中的作用研究[J]. 器官移植, 2024, 15(6):895-902. |
| Li X F, Hao Q S, Gao X, et al. Study on SIRT1-NLRP3 axis-mediated pyroptosis in the role of remifentanil against liver ischemia-reperfusion injury[J]. Organ Transplantation, 2024, 15(6):895-902. doi:10.3969/j.issn.1674-7445.2024128. | |
| [16] | 黄远, 刘日光, 张沕, 等. 膝关节骨关节炎相关炎症及软骨代谢标志物的表达与临床意义[J]. 中国骨质疏松杂志, 2021, 27(11):1614-1619,1625. |
| Huang Y, Liu R G, Zhang M, et al. Expression and clinical significance of KOA-related inflammation and cartilage metabolic markers[J]. Chinese Journal of Osteoporosis, 2021, 27(11):1614-1619,1625. doi:10.3969/j.issn.1006-7108.2021.11.011. | |
| [17] | 高辉, 吴江, 李超. 脐带间充质干细胞对骨质疏松大鼠骨密度相关指标及Wnt/β-catenin/Runx2信号通路的影响[J]. 锦州医科大学学报, 2023, 44(5):20-25. |
| Gao H, Wu J, Li C. Effect of umbilical cord mesenchymal stem cells on bone mineral density and Wnt/β-catenin/Runx2 signaling pathway in rats with osteoporosis[J]. Journal of Jinzhou Medical University, 2023, 44(5):20-25. | |
| [18] | Paulissen G, Malaise O, Deroyer C, et al. JAK inhibitors alleviate metabolic dysregulation,inflammation and fibrosis in osteoarthritis:insights from human joint cells and synovium[J]. Rheumatology (Oxford), 2025, 64(10):5539-5550. doi:10.1093/rheumatology/keaf298. |
| [19] | He R, Wei Y, Peng Z, et al. α-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4/SLC7A11/GPX4 signaling pathway[J]. Cell Mol Biol Lett, 2024, 29(1):88. doi:10.1186/s11658-024-00605-6. |
| [20] | Wen J, Yi L, Chen L, et al. Short-term DMOG treatment rejuvenates senescent mesenchymal stem cells by enhancing mitochondrial function and mitophagy through the HIF-1α/BNIP3 pathway[J]. Stem Cell Res Ther, 2025, 16(1):274. doi:10.1186/s13287-025-04422-2. |
| [21] | Deng R, Wang Y, Bu Y, et al. BNIP3 mediates the different adaptive responses of fibroblast-like synovial cells to hypoxia in patients with osteoarthritis and rheumatoid arthritis[J]. Mol Med, 2022, 28(1):64. doi:10.1186/s10020-022-00490-9. |
| [22] | Hu S, Zhang C, Ni L, et al. Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy[J]. Cell Death Dis, 2020, 11(6):481. doi:10.1038/s41419-020-2680-0. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||